Skip to main content
OpenTrials
Completed

NCT Number: NCT01786291

PAP Therapy Sleep Apnea and Exercise

Positive airway pressure (PAP) therapy is generally offered to patients with obstructive sleep apnea. The investigators suggest that beneficial effects of PAP therapy is by preventing apneas and therefore reducing cardiac and pulmonary morbidities. The investigators sought to verify this by assessing cardiac and pulmonary function during exercise.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Gaziantep, Faculty of Medicine, Dept. of Pulmonary Diseases

Gaziantep, 27310, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • obstructive sleep apnea diagnosed by polysomnography
  • CPAP therapy indicated

Exclusion criteria

  • obstructive or restrictive lung disease
  • cardiac failure
  • acute coronary syndrome
  • inability to cycle

Treatment and study plan

Primary outcomes

  1. peak oxygen uptake

    Time frame: 30-60 days

Secondary outcomes

  1. ventilatory equivalent for carbon dioxide at anaerobic threshold

    Time frame: 30-60 days

Sponsors and collaborators

Lead sponsor

University of Gaziantep

Other

Registry information

Official study title

Effects of Positive Airway Pressure Therapy on Exercise Parameters in Obstructive Sleep Apnea

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Feb 7, 2013
Registry last updated
Feb 7, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.